Table 1.

Baseline patient characteristics (N = 40)

Clinical characteristicsNumber of patients (%)
Age
 Mean ± SD52.0 ± 10.2
 Median, range52 (22–74)
Gender
 Male35 (87.5)
 Female5 (12.5)
Performance status (ECOG)
 034 (85.0)
 16 (15.0)
Histology
 Keratinizing squamous cell carcinoma1 (2.5)
 Nonkeratinizing or poorly differentiated carcinoma3 (7.5)
 Undifferentiated carcinoma36 (90.0)
Disease stage
 Regional and metastatic disease2 (5.0)
 Metastatic disease only38 (95.0)
Previous chemotherapya40 (100)
 Carboplatin33
 Cisplatin32
 Gemcitabine32
 Paclitaxel21
 Capecitabine18
 5-FU6
 Docetaxel6
 MK22062
 MVA EBV Vaccine2
 Cetuximab1
 Oxaliplatin1
 TAS1061
Number of lines of prior chemotherapy received
 Mean ± SD3.3 ± 1.2
 Median, range3 (1–6)
Previous radiotherapy39 (97.5)
Previous surgery2 (5.0)
  • aIncludes all settings: neoadjuvant, concurrent, adjuvant, recurrent, and metastatic.